GT Biopharma, Inc. (GTBP): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2019-12-31
$36.0K2011-12-31: $02012-12-31: $2.0K2013-12-31: $02014-12-31: $6.0K2015-12-31: $1.0K2016-12-31: $02017-12-31: $4.0K2018-12-31: $36.0K2019-12-31: $0$0
2011-12-31 Capital Expenditures (USD) 2019-12-31
Period endedCapital ExpendituresChange YoYSource filing
2019-12-31$0-100.0%2020-03-27, From 2019-01-01
2018-12-31$36.0K+800.0%2020-03-27, From 2018-01-01
2017-12-31$4.0Kn/a2019-03-29, From 2017-01-01
2016-12-31$0-100.0%2018-03-01, From 2016-01-01
2015-12-31$1.0K-83.3%2018-02-28, From 2015-01-01
2014-12-31$6.0Kn/a2018-02-28, From 2014-01-01
2013-12-31$0-100.0%2015-03-31, From 2013-01-01
2012-12-31$2.0Kn/a2015-01-08, From 2012-01-01
2011-12-31$0n/a2014-11-18, From 2011-01-01